Should be used during pregnancy only if potential benefits justify potential risk to the fetus. Caution when administered to nursing women. Mometasone furoate: Discontinue therapy if hypersensitivity reactions occur. Discontinue therapy & institute appropriate local or systemic therapy, if needed, when Candida infection develops. Risk of epistaxis; localized nose & pharynx infections w/
Candida albicans; impaired wound healing; glaucoma &/or cataracts. Reports of nasal septum perforation. Periodically examine for possible changes in nasal mucosa in patients using nasal spray over several mth or longer. Patients w/immunosuppression; active or quiescent tuberculous infection of the resp tract; untreated fungal, bacterial, systemic viral infections; ocular herpes simplex. May cause reduction in growth velocity when administered to ped patients. Azelastine HCl: Occurrence of somnolence. Caution against engaging in hazardous occupations requiring complete mental alertness & motor coordination (eg, operating machinery or driving motor vehicle). Safety & effectiveness in ped patients <12 yr have not been established.